Indications
Therapeutic Asset Ratings
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Sirolimus
Graft Versus Host Disease
Zachariah Michael DeFilipp
P3
BBB
(74)
Sirolimus
Plasma Cell Myeloma
National Cancer Institute (NCI)
P3
BBB
(74)
Solanezumab
Alzheimer Disease
Eli Lilly and Company
P3
BBB
(74)
Sulfamethoxazole
Plasma Cell Myeloma
Monash University
P3
BBB
(74)
Survodutide
Obesity Disorder
Boehringer Ingelheim
P3
BBB
(74)
Tacrolimus
Acute Leukemia
Masonic Cancer Center, University of Minnesota
P3
BBB
(74)
Tacrolimus
Acute Myeloid Leukemia
City of Hope Medical Center
P3
BBB
(74)
Tacrolimus
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Center for International Blood and Marrow Transplant Research
P3
BBB
(74)
Tacrolimus
Myeloproliferative Neoplasm
Stanford University
P3
BBB
(74)
Tacrolimus
Disease Related To Hematopoietic Stem Cell Transplant
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
P3
BBB
(74)
Tacrolimus
Plasma Cell Myeloma
Thomas Jefferson University
P3
BBB
(74)
Tacrolimus
Mantle Cell Lymphoma
University of Michigan Rogel Cancer Center
P3
BBB
(74)
Tacrolimus
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
City of Hope Medical Center
P3
BBB
(74)
Testosterone Undecylate
Breast Cancer
Aminex Therapeutics, Inc.
P3
BBB
(74)
Thioguanine Anhydrous
Acute Myeloid Leukemia
Columbia University
P3
BBB
(74)
Thioguanine Anhydrous
B-Cell Acute Lymphoblastic Leukemia
SWOG Cancer Research Network
P3
BBB
(74)
Thioguanine Anhydrous
T-Cell Acute Lymphoblastic Leukemia
SWOG Cancer Research Network
P3
BBB
(74)
Thioguanine Anhydrous
T-Lymphoblastic Lymphoma
Children's Oncology Group
P3
BBB
(74)
Thiotepa
Acute Myeloid Leukemia
Sawa Ito, MD
P3
BBB
(74)
Thiotepa
Breast Cancer
The Netherlands Cancer Institute
P3
BBB
(74)
Toripalimab
Non-Small Cell Lung Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
P3
BBB
(74)
Trastuzumab Deruxtecan
Non-Small Cell Lung Carcinoma
National Cancer Institute (NCI)
P3
BBB
(74)
Trastuzumab Emtansine
Breast Cancer
SWOG Cancer Research Network
P3
BBB
(74)
Treosulfan
Acute Myeloid Leukemia
Institut Paoli-Calmettes
P3
BBB
(74)
Trimethoprim
Plasma Cell Myeloma
Monash University
P3
BBB
(74)
Showing 2026 to 2050 of 42,289 assets
Previous
Page 82 of 1692
Next